Medexus Pharmaceuticals Inc.

C$5.12As of Sun 8 Nov 2026, 12:00 UTC
TSX:MDPHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR 3.36%
Div yield —
ROE (4.68%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.68
PE TTM —
TSR TTM 82.86%
Mkt cap C$160.9M
ROIC 10.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.41
5.69%
(0.64%)
Hold 5|6|11|1|5
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.10
0.10
0.11
0.12
30.79%
29.60%
25.25%
27.22%
Revenue$M
8.082
8.435
8.299
8.520
10.03%
17.58%
11.81%
11.21%
Peers (US$113.9M)
Cap (US$)
PE
124.8M
1.968x
113.3M
8.148x
Capital
TTM
5Y
10Y
Leveragex
4.981
0.228
0.193
EBIT/Intx
2.481
0.115
0.120
Own earn%
79.59
(181.71)
(111.45)
Sh yield%
9.42
32.16
32.47
Owners
Insiders/Inst%
8.88
89.69
Short interest%
3.59
SBC / revenue%
3.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–24
$1 testx
0.0
Incr. ROIC%
−1